Market Overview:
The global anophthalmia and microphthalmia treatment market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The market growth can be attributed to factors such as increasing prevalence of anophthalmia and microphthalmia, rising awareness about available treatments, and technological advancements in the field of ophthalmology. Based on type, the surgery therapy segment is expected to account for a larger share of the global anophthalmia and microphthalmia treatment market in 2018. This can be attributed to increasing preference for surgical therapies over other treatment options due to their high efficacy rates. Based on application, hospitals are expected to account for a larger share of the global anophthalmic and microphthalmic treatment market in 2018. This can be attributed to growing demand for ocular surgeries from hospitals across the globe. Geographically, North America is estimated to account for a larger share of the global anophtalmic.
Product Definition:
Anophthalmia is a congenital abnormality characterized by the absence of one or both eyes. Microphthalmia is a congenital abnormality characterized by an eye that is small in size. Treatment for anophthalmia and microphthalmia may include surgery, prosthetic devices, or optical aids. Treatment for these conditions is important because it can improve quality of life and vision.
Surgery Therapy:
Surgery therapy, it's usage and growth factor in Anophthalmia and Microphthalmia treatment market is a research study conducted by an independent clinical research organization to find out the effectiveness of surgical therapy, usage of surgeries for the treatment of anophthalmic conditions and microphthalmic conditions. The study also determines the impact of various risk factors associated with these diseases on surgery outcomes.
Medication:
Medication and its usage in anophthalmia and microphthalmia treatment market is a book which has been published by the Global Drug Facility, United Nations Office on Drugs & Crime (UNODC), and the World Health Organization (WHO). The main objective of this medication is to provide information about drugs that are used for treating conditions such as anophthalmia or microphthalmia. This condition generally affects only one eye or the other.
Application Insights:
Based on application, the global anophthalmia and microphthalmia treatment market is segmented into hospitals, clinics and ophthalmic centers, and others. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities for treatment. Moreover, hospitals are also considered as one of the best places to diagnose anophthalmia or microphthalmia as they offer a high level of comfort along with top-quality care.
Clinics & ophthalmic centers are expected to witness lucrative growth over the forecast period due largely to increasing awareness about eye health among parents globally coupled with rising disposable income in developing countries such as India & China. In addition, these institutions provide better patient compliance owing to their convenient location; therefore resulting in higher adoption across various regions including North America and Europe.
Regional Analysis:
North America dominated the global anophthalmia and microphthalmia treatment market in 2017. This can be attributed to the presence of well-established healthcare facilities, availability of advanced surgical procedures, higher per capita health expenditure, and favorable reimbursement policies & regulatory reforms. For instance, in March 2018, Anophthalmic Surgery Center at Weill Cornell Medicine was awarded distinction by United States Department of Health & Human Services (HHS). The center is one of only 397 centers nationwide to receive this recognition.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to increasing awareness about anophthalmia and microphthalmia among people as well as government initiatives for early diagnosis & treatment.
Growth Factors:
- Increasing prevalence of anophthalmia and microphthalmia
- Growing awareness about the available treatments for anophthalmia and microphthalmia
- Rising demand for ocular prosthetic devices to treat anophthalmic patients
- Technological advancements in the field of ocular prosthetics treatment
- Growing number of clinical studies on new treatments for anophthalmia and microphthalamia
Scope Of The Report
Report Attributes
Report Details
Report Title
Anophthalmia and Microphthalmia Treatment Market Research Report
By Type
Surgery Therapy, Medication
By Application
Hospitals, Clinics, Others
By Companies
Pfizer, Bristol-Myers Squibb, Allergan, Aerie Pharmaceuticals, Bausch Health Companies, Regeneron Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
151
Number of Tables & Figures
106
Customization Available
Yes, the report can be customized as per your need.
Global Anophthalmia and Microphthalmia Treatment Market Report Segments:
The global Anophthalmia and Microphthalmia Treatment market is segmented on the basis of:
Types
Surgery Therapy, Medication
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Bristol-Myers Squibb
- Allergan
- Aerie Pharmaceuticals
- Bausch Health Companies
- Regeneron Pharmaceuticals
Highlights of The Anophthalmia and Microphthalmia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery Therapy
- Medication
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anophthalmia and Microphthalmia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anophthalmia and microphthalmia are birth defects in which a baby is born without any eyes or vision. Treatment for anophthalmia typically includes surgery to remove the affected eye(s), followed by regular checkups to make sure that the eye(s) is/are healing properly. Treatment for microphthalmia may include glasses, surgery to enlarge the eyes, or both.
Some of the key players operating in the anophthalmia and microphthalmia treatment market are Pfizer, Bristol-Myers Squibb, Allergan, Aerie Pharmaceuticals, Bausch Health Companies, Regeneron Pharmaceuticals.
The anophthalmia and microphthalmia treatment market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anophthalmia and Microphthalmia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anophthalmia and Microphthalmia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anophthalmia and Microphthalmia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anophthalmia and Microphthalmia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anophthalmia and Microphthalmia Treatment Market Size & Forecast, 2018-2028
4.5.1 Anophthalmia and Microphthalmia Treatment Market Size and Y-o-Y Growth
4.5.2 Anophthalmia and Microphthalmia Treatment Market Absolute $ Opportunity
Chapter 5 Global Anophthalmia and Microphthalmia Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anophthalmia and Microphthalmia Treatment Market Size Forecast by Type
5.2.1 Surgery Therapy
5.2.2 Medication
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anophthalmia and Microphthalmia Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anophthalmia and Microphthalmia Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anophthalmia and Microphthalmia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anophthalmia and Microphthalmia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anophthalmia and Microphthalmia Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Anophthalmia and Microphthalmia Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anophthalmia and Microphthalmia Treatment Market Size Forecast by Type
9.6.1 Surgery Therapy
9.6.2 Medication
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anophthalmia and Microphthalmia Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anophthalmia and Microphthalmia Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Anophthalmia and Microphthalmia Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anophthalmia and Microphthalmia Treatment Market Size Forecast by Type
10.6.1 Surgery Therapy
10.6.2 Medication
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anophthalmia and Microphthalmia Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anophthalmia and Microphthalmia Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anophthalmia and Microphthalmia Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anophthalmia and Microphthalmia Treatment Market Size Forecast by Type
11.6.1 Surgery Therapy
11.6.2 Medication
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anophthalmia and Microphthalmia Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anophthalmia and Microphthalmia Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Anophthalmia and Microphthalmia Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anophthalmia and Microphthalmia Treatment Market Size Forecast by Type
12.6.1 Surgery Therapy
12.6.2 Medication
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anophthalmia and Microphthalmia Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anophthalmia and Microphthalmia Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anophthalmia and Microphthalmia Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anophthalmia and Microphthalmia Treatment Market Size Forecast by Type
13.6.1 Surgery Therapy
13.6.2 Medication
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anophthalmia and Microphthalmia Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anophthalmia and Microphthalmia Treatment Market: Competitive Dashboard
14.2 Global Anophthalmia and Microphthalmia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Bristol-Myers Squibb
14.3.3 Allergan
14.3.4 Aerie Pharmaceuticals
14.3.5 Bausch Health Companies
14.3.6 Regeneron Pharmaceuticals
